Atlas Trials

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma

Clinical trial NCT00022893 · UNKNOWN

Trial details

NCT number
NCT00022893
Sponsor
Corixa Corporation
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-Hodgkin's Lymphoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.